Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax

BACKGROUND: Disease caused by Bacillus anthracis is often accompanied by high mortality primarily due to toxin-mediated injury. In the early disease course, anthrax toxins are secreted; thus, antibiotic use is limited to the early stage. In this regard, antibodies against the toxin component, protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Qi, Xiong, Siping, Liang, Xudong, Kuai, Xingwang, Wang, Yiwen, Wang, Changjun, Feng, Zhenqing, Zhu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288905/
https://www.ncbi.nlm.nih.gov/pubmed/30526504
http://dx.doi.org/10.1186/s12879-018-3542-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288905/
https://www.ncbi.nlm.nih.gov/pubmed/30526504
http://dx.doi.org/10.1186/s12879-018-3542-6

Ejemplares similares